What is OCO Biomedical?
OCO Biomedical, founded in 1977, is a U.S.-based manufacturer specializing in comprehensive dental implant solutions. The company provides a diverse portfolio of dental implants, prosthetic components, and regenerative products, all produced with a commitment to high quality and user-friendliness. OCO Biomedical is recognized for its innovative technology, which sets industry benchmarks for restorative dental procedures. The company also actively engages in providing educational resources and training courses for dental professionals, aiming to elevate their expertise in utilizing advanced implant systems.
How much funding has OCO Biomedical raised?
OCO Biomedical has raised a total of $410K across 2 funding rounds:
Debt
$150K
Debt
$260K
Debt (2020): $150K with participation from PPP
Debt (2021): $260K led by PPP
What's next for OCO Biomedical?
The substantial late-stage funding indicates OCO Biomedical is poised for significant expansion and further technological development. This strategic capital infusion is likely to fuel advancements in product innovation, market penetration, and potentially acquisitions within the competitive dental implant industry. The company's focus on quality and education positions it for sustained growth and leadership in providing advanced solutions to dental practitioners.
See full OCO Biomedical company page
